General Information of Drug (ID: DMCMJRA)

Drug Name
EGF816 Drug Info
Cross-matching ID
PubChem CID
72703790
ChEBI ID
CHEMBL3787344
CAS Number
CAS 1508250-71-2
TTD Drug ID
D0K7FY

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Steroid biosynthesis 2.68 0.00e+0 19/20 (95%) DHCR24;MSMO1;SQLE;...
Biosynthesis of unsaturated fatty acids 2.19 0.00e+0 21/27 (77.78%) SCD;ELOVL6;FADS1;...
Lysosome 2.16 0.00e+0 115/128 (89.84%) NEU1;TPP1;MCOLN1;...
Terpenoid backbone biosynthesis 2.12 0.00e+0 18/22 (81.82%) HMGCS1;ACAT2;FDPS;...
Synthesis and degradation of ketone bodies 1.97 5.11e-3 9/10 (90%) HMGCS1;ACAT2
PPAR signaling pathway 1.89 8.52e-3 66/74 (89.19%) SCD;HMGCS1;ACSL1;...
Collecting duct acid secretion 1.85 1.34e-2 22/27 (81.48%) ATP6V0D1;ATP6V1C1;ATP6V1B2;...
Fatty acid elongation 1.78 2.87e-2 19/27 (70.37%) ELOVL6;ELOVL4;ELOVL5;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 2.5uM - 20uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 2.5uM - 20uM 24H